Competing interest declarations and management
Competing interest declarations and management
Working Party Members were asked to declare in writing, any interests relevant to the guideline development, prior to commencement. Members were asked to update their information if they became aware of any changes to their interests.
All declarations were added to a register of interests as listed below. The register was made available to the Working Party throughout the development of the guideline, allowing members to take any potential conflicts of interest into consideration during discussions, decision making and formulation of recommendations.
If Working Party Members were identified as having a significant real or perceived conflict of interest, the Chair could decide that the member either leave the discussion whilst the specific area they were conflicted in was discussed or the member could remain present but not participate in the discussion, or decision making on the specific area where they were conflicted. There were no instances where this occurred during the development of this guideline.
Guideline working party members are responsible to update their conflict of interest statements if a new interest arises. The members will receive a formal reminder to review their statements and ensure it is up-to-date prior to the yearly meetings that will be scheduled to review all updates.
|Working party member||Competing interest declaration|
|Angelique Levert||No competing interest to declare.|
|Associate Professor Alan Moss MBBS (Hons) MD, FRACP||No competing interest to declare.|
|Associate Professor Bernard Mark Smithers||National Advisory Board for Novartis on the management of GIST. No payment received for this service at this time.|
|Associate Professor Christophe Rosty, MD PhD FRCPA||No competing interest to declare.|
|Associate Professor Freddy Sitas||No competing interest to declare.|
|Associate Professor Geoffrey Hebbard||Has received Research Support, Travel Grants and sponsorship of educational activities from the manufacturers and local distributors of all PPIs, H2Receptor Antagonists and Prokinetics. Has had, but has no current consultancies with any of those companies.
Has received support for sponsorship of educational activities from medical device manufacturers with products relevant to the diagnosis and management of patients with Barrett’s Oesophagus. Has no shares or other financial links with the manufacturer or distributors of any of the relevant pharmaceutical or device manufacturing companies. Owns shares in The Gut Shop, a company that distributes equipment used in the assessment of patients with gastrooesophageal reflux disease, including patients with Barrett’s Oesophagus.
|Associate Professor Guy Eslick||No competing interest to declare.|
|Associate Professor Ian Norton MBBS, PhD, FRACP||From 2008-2013 was a member of a steering committee for an Astra Zeneca sponsored educational meeting. Honorarium payment involved.
Currently member of Advisory Board for Olympus Australia.
|Associate Professor Jurgen Stahl FRCPA||No competing interest to declare.|
|Associate Professor Neil Walker MD, FRCPA||No competing interest to declare.|
|Associate Professor Sarah J (Sally) Lord MBBS MSc(Applied Biostatistics and Epidemiology)||Married to Working Party member Reginald Lord.|
|Clinical Professor Marian Priyanthi Kumarasinghe||No competing interest to declare|
|David Whiteman||No competing interest to declare.|
|Dr Adrian Chung MBBS, BMed Sci, FRACP||No competing interest to declare.|
|Dr Andrew Clouston MBBS PhD FRCPA||No competing interest to declare.|
|Dr Andrew Taylor MBBS MD FRACP||No direct competing interest.
Previous recipient of Victorian State Department of Health New Technology Grant to establish endoscopic treatment programme for dysplastic Barrett’s oesophagus statewide programme at St Vincent’s Hospital and in conjunction with Prof Finlay Macrae, Royal Melbourne Hospital. This funding enabled purchase of Halo Radiofrequency Ablation equipment for three years 2009-2011. No specific further funding since then.
|Dr Bradley Kendall MBBS, FRACP||No competing interest to declare.|
|Dr Catherine Campbell MBBS, FRCPA||No competing interest to declare.|
|Dr Darren A. Pavey MBBS FRACP||No competing interest to declare.|
|Dr Eric Y Lee BSc(Med) MBBS Hons FRACP||No competing interest to declare|
|Dr Farzan Fahrtash Bahin, MBBS (Hons), MPhil (Med)||No competing interest to declare.|
|Dr Florian Grimpen, MD, FRACP||No competing interest to declare.|
|Dr Henry To||No competing interest to declare.|
|Dr Iain Thomson MBBS, FRACS||No competing interest to declare.|
|Dr Ian Brown FRCPA||No competing interest to declare.|
|Dr Ian Faud Yusoff MBBS, FRACP||No competing interest to declare|
|Dr Jeremy Dwyer MBBS (Hons)||No competing interest to declare.|
|Dr Louisa Gordon||No competing interest to declare.|
|Dr Luke Hourigan MBBS FRACP||Member of ANZELF research group and has received sponsorship to attend annual scientific meeting sponsored by Olympus Australia|
|Dr Mark Appleyard MD FRACP MRCP MBBS BSc||Has received financial support from Olympus to attend educational conferences; equipment support for clinical research and financial support for clinical research staff.|
|Dr Mark Schoeman MBBS, PhD, FRACP, AGAF||No competing interest to declare.|
|Dr Oliver Maximilian Fisher, MD||Supported by a grant from the Swiss Cancer League (BIL KLS-3133-02-2013).|
|Dr Spiro Raftopoulos||No competing interest to declare.|
|Dr Sutharshan Kannuthurai||No competing interest to declare.|
|Dr W Bastiaan de Boer MBBS, BMedSci, FRCPA||No competing interest to declare.|
|Dr Yuri Veniaminovich Bobryshev PhD||No competing interest to declare|
|Erfan Jaberiyanfar||No competing interest to declare.|
|Melissa Thomas||No competing interest to declare.|
|Ms Qingwei Luo||No competing interest to declare.|
|Peter Sarich||No competing interest to declare.|
|Professor David Watson MBBS, MD, FRACS||No competing interest to declare.|
|Professor James Kench||No competing interest to declare.|
|Professor Jon Emery MA, MBBCh, FRACGP, MRCGP, DPhil||Chief investigator on a research project investigating a non-endoscopic approach to screening for Barrett’s oesophagus in primary care. No pecuniary interest in the associated cytosponge screening test.|
|Professor Michael Bourke MBBS, FRACP||No competing interest to declare.|
|Professor Prithi S Bhathal, MBBS PhD FRCPA||No competing interest to declare.|
|Professor Rajvinder Singh MBBS MRCP MPhil FRACP AM FRCP||No competing interest to declare.|
|Professor Reginald V Lord MBBS MD FRACS||Married to Working Party member Sarah (Sally) Lord|
|Professor Shan Rajendra MBBCh, MSc, MRCP. MD, FRCP, FRCPE, FRACP||Member of Medical Advisory Committee, GI Dynamics, Australia.|
|Sonali Munot||No competing interest to declare.|
Derek Maule - No competing interest to declare.